Love the definitive views Max!
- Time will indeed tell. Continuing good results in the absence of competition will ultimately make my case.
- BTW - Opportunity cost is the potential forgone profit from a missed opportunity (Investopedia) ie what you'd miss out on if you don't own it, and it receives a T/O offer or other uplift.
- An anecdotal example of another stock doesn't mean much tbh mate. Part of the reason why I like this stock is its potential for broad-spectrum and its novel approach, in addition to its track record. ie its not ''any'' bio.
- I was wondering whether we'd satisfy the "Future made in Australia" criteria this afternoon. Presumably a little too far from the current stated intent of the act, but equally likely too early tell today, Could it garner support as the legislative process continues. COVID is very high profile. I'd have someone look at it if I was MM. Might get look in under science or disaster areas? At any rate, the point is there a stated appetite for domestic business development & there's options for business out there that aren't CR or are not completely CR centric. Very saleable concept with results.
- Forums
- ASX - By Stock
- BIT
- No More CR until FULL RESULTS are available and better
No More CR until FULL RESULTS are available and better, page-70
-
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BIT (ASX) to my watchlist
|
|||||
Last
3.5¢ |
Change
0.002(6.06%) |
Mkt cap ! $31.57M |
Open | High | Low | Value | Volume |
3.3¢ | 3.5¢ | 3.3¢ | $19.27K | 566.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 299989 | 3.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.5¢ | 371664 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 100000 | 0.036 |
2 | 30126 | 0.035 |
2 | 315189 | 0.034 |
4 | 330768 | 0.033 |
2 | 242406 | 0.032 |
Price($) | Vol. | No. |
---|---|---|
0.035 | 374664 | 4 |
0.036 | 65500 | 1 |
0.037 | 537816 | 2 |
0.039 | 430546 | 2 |
0.040 | 113240 | 2 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
BIT (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online